Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Dasatinib × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Burkitt Lymphoma 4 Leukemia, Myeloid, Chronic-Phase 3 Leukemia 3 Philadelphia Chromosome 2 Neoplasms 2 Leukemia, Myeloid, Acute 2 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mastocytosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hypereosinophilic Syndrome 1 Glioma 1 Frailty 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Carboplatin 19 durvalumab 18 Etoposide 18 atezolizumab 17 PM 01183 10 Topotecan 8 pembrolizumab 6 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Drug Therapy 5 Paclitaxel 4 Bevacizumab 4 AMG 757 4 anlotinib 3 amrubicin 3 Temozolomide 3 Radiotherapy 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 tremelimumab 2 toripalimab 2 sacituzumab govitecan 2 olaparib 2 monalizumab 2 enzalutamide 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡